Abstract
Ninety-seven fresh explants of human tumours have been cultured in vitro in an attempt to predict their sensitivity to subsequent cytotoxic chemotherapy. Only 3/26 solid ovarian tumours were cultured successfully although 12 of the 23 which failed to grow proved later to have benign histology. Of 10 solid tumours from other sites, only 2/4 renal tumours and one melanoma were successfully grown and tested in vitro. A higher success rate was achieved in culturing carcinoma cells of ovarian (10/22) and breast (10/22) origin from ascitic and pleural fluids. Using increase in cell number after 7 days' growth in vitro as the biological end-point, concentrations of cytotoxic drugs which are achievable in patients produced significant effects on some tumour explants. Detailed studies of serial subcultures in vitro from an ovarian tumour showed that large changes in chemosensitivity occur within about 2 passages, in vitro, so that sensitivity testing can only be carried out using fresh explants or their first subcultures if any possible correlation between in vitro cytotoxicity and in situ response is to be studied. Clinical effectiveness and in vitro chemosensitivity are compared for a limited number of patients with ovarian and breast carcinomata for whom follow-up information was available; no useful correlation was found.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Balconi G., Bossi A., Donelli M. G., Filippeschi S., Franchi G., Morasca L., Garattini S. Chemotherapy of a spontaneous mammary carcinoma in mice: relation between in vitro-in vivo activity and blood and tumor concentrations of serveral antitumor drugs. Cancer Chemother Rep. 1973 Apr;57(2):115–124. [PubMed] [Google Scholar]
- Holmes H. L., Little J. M. Tissue-culture microtest for predicting response of human cancer to chemotherapy. Lancet. 1974 Oct 26;2(7887):985–987. doi: 10.1016/s0140-6736(74)92075-3. [DOI] [PubMed] [Google Scholar]
- Limburg H. G. Chemotherapy in the treatment of ovarian cancer. Proc R Soc Med. 1969 Apr;62(4):361–362. [PMC free article] [PubMed] [Google Scholar]
- Mitchell J. S., Dendy P. P., Dawson M. P., Wheeler T. K. Testing anti-cancer drugs. Lancet. 1972 Apr 29;1(7757):955–955. doi: 10.1016/s0140-6736(72)91515-2. [DOI] [PubMed] [Google Scholar]
- WRIGHT J. C., COBB J. P., GUMPORT S. L., GOLOMB F. M., SAFADI D. Investigation of the relation between clinical and tissue-culture response to chemotherapeutic agents on human cancer. N Engl J Med. 1957 Dec 19;257(25):1207–1211. doi: 10.1056/NEJM195712192572502. [DOI] [PubMed] [Google Scholar]
- Wolberg W. H. Biochemical approaches to prediction of response in solid tumors. Natl Cancer Inst Monogr. 1971 Dec;34:189–195. [PubMed] [Google Scholar]